Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sirs, In terms of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached a copy of the advertisement published in Financial Express (English daily) and Financial Express (Gujarati daily) dated 7th February, 2019 intimating that a Board Meeting of the Company is scheduled to be convened on Thursday, the 14th day of February, 2019 to, inter-alia, consider, approve and take on record the Standalone Unaudited Financial Results of the Company for the third quarter and nine months ended 31st December, 2018.
08-02-2019
Bigul

Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Reg. 29 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant to Regulations 29(1)(a) and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to notify that a meeting of the Board of Directors of the Company is proposed to be held on Thursday, the 14th February, 2019 at registered office of the Company at 1:00 PM. to, inter-alia, consider, approve and take on record the Standalone Unaudited Financial Results of the Company for the third quarter ended 31st December, 2018. Further, the trading window shall remain closed for all designated persons including promoters, directors, key managerial personnel, designated employees and other connected persons of the Company with immediate effect till completion of 48 hours after the Standalone Unaudited Financial Results are submitted to the stock exchanges. Thanking you,
04-02-2019
Bigul

Parmax Pharma Ltd - 540359 - Shareholding for the Period Ended December 31, 2018

 Parmax Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here
21-01-2019
Bigul

Parmax Pharma Ltd - 540359 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pravina Mahasukhlal Gopani
21-01-2019
Bigul

Parmax Pharma Ltd - 540359 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pravina Mahasukhlal Gopani
19-01-2019
Bigul

Parmax Pharma Ltd - 540359 - Statement Of Investor Complaints For The Quarter Ended December 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mr. Alkesh R. GosaliaDesignation :- Director
15-01-2019
Bigul

Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sirs, In terms of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached a copy of the advertisement clipping of Extract of Standalone Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2018 published in Financial Express (English daily) and Financial Express (Gujarati daily) dated 13th November, 2018 which were approved at the Board...
13-11-2018
Bigul

1. Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2018. 2. Limited Review Report For The Quarter And Half Year Ended 30Th September, 2018

 Dear Sirs, This is to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 11th November, 2018, inter-alia, considered and approved the Unaudited Financial Results for quarter and half year ended 30th September, 2018. The same has also been reviewed by the Audit Committee in its meeting held today. A copy of the Statement of Unaudited Financial Results for the quarter and half year ended 30th September,...
11-11-2018
Bigul

Outcome of Board Meeting

 This is to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 11th November, 2018, inter-alia, considered and approved the Unaudited Financial Results for quarter and half year ended 30th September, 2018. The same has also been reviewed by the Audit Committee in its meeting held today. A copy of the Statement of Unaudited Financial Results for the quarter and half year ended 30th September, 2018, approved...
11-11-2018
Bigul

Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sirs, In terms of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached a copy of the advertisement published in Financial Express (English daily) and Financial Express (Gujarati daily) dated 5th November, 2018 intimating that a Board Meeting of the Company is scheduled to be convened on Sunday, the 11th day of November, 2018 to, inter-alia, consider, approve and take on record the...
05-11-2018
Next Page
Close

Let's Open Free Demat Account